Stockreport

Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF Officinae Bio’s breakthroughs in AI-enabled methodologies for nucleic manufacturing to enhance Maravai’s mRNA manufacturing capabilities within the TriLink BioTechnologi [Read more]